Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2009 5
2010 2
2013 1
2014 2
2015 5
2016 5
2017 2
2018 3
2019 2
2020 3
2021 2
2022 7
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Identification of Potent DNA Gyrase Inhibitors Active against Mycobacterium tuberculosis.
Pakamwong B, Thongdee P, Kamsri B, Phusi N, Kamsri P, Punkvang A, Ketrat S, Saparpakorn P, Hannongbua S, Ariyachaokun K, Suttisintong K, Sureram S, Kittakoop P, Hongmanee P, Santanirand P, Spencer J, Mulholland AJ, Pungpo P. Pakamwong B, et al. Among authors: saparpakorn p. J Chem Inf Model. 2022 Apr 11;62(7):1680-1690. doi: 10.1021/acs.jcim.1c01390. Epub 2022 Mar 29. J Chem Inf Model. 2022. PMID: 35347987
Bioisosteric Design Identifies Inhibitors of Mycobacterium tuberculosis DNA Gyrase ATPase Activity.
Kamsri B, Pakamwong B, Thongdee P, Phusi N, Kamsri P, Punkvang A, Ketrat S, Saparpakorn P, Hannongbua S, Sangswan J, Suttisintong K, Sureram S, Kittakoop P, Hongmanee P, Santanirand P, Leanpolchareanchai J, Goudar KE, Spencer J, Mulholland AJ, Pungpo P. Kamsri B, et al. Among authors: saparpakorn p. J Chem Inf Model. 2023 May 8;63(9):2707-2718. doi: 10.1021/acs.jcim.2c01376. Epub 2023 Apr 19. J Chem Inf Model. 2023. PMID: 37074047
Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity.
Thongdee P, Hanwarinroj C, Pakamwong B, Kamsri P, Punkvang A, Leanpolchareanchai J, Ketrat S, Saparpakorn P, Hannongbua S, Ariyachaokun K, Suttisintong K, Sureram S, Kittakoop P, Hongmanee P, Santanirand P, Mukamolova GV, Blood RA, Takebayashi Y, Spencer J, Mulholland AJ, Pungpo P. Thongdee P, et al. Among authors: saparpakorn p. J Chem Inf Model. 2022 Dec 26;62(24):6508-6518. doi: 10.1021/acs.jcim.2c00531. Epub 2022 Aug 22. J Chem Inf Model. 2022. PMID: 35994014
In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions.
Hanwarinroj C, Thongdee P, Sukchit D, Taveepanich S, Kamsri P, Punkvang A, Ketrat S, Saparpakorn P, Hannongbua S, Suttisintong K, Kittakoop P, Spencer J, Mulholland AJ, Pungpo P. Hanwarinroj C, et al. Among authors: saparpakorn p. J Mol Graph Model. 2022 Sep;115:108231. doi: 10.1016/j.jmgm.2022.108231. Epub 2022 May 28. J Mol Graph Model. 2022. PMID: 35667143
41 results